8-K current report · filed Nov 9, 2026

Turning Point Brands, Inc. (TPB) 8-K Current Report: November 9, 2026

Item 2.02Item 7.01Item EX-99.1TPB overview

Short answer

Turning Point Brands, Inc. (TPB) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Third-quarter results for the three months ended September 30, 2026 announced by Turning Point Brands.

Turning Point Brands, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Third-quarter results for the three months ended September 30, 2026 announced by Turning Point Brands
  • Full financial details and management commentary in Exhibit 99.1 press release

Item 7.01 · Regulation FD Disclosure

  • Investor presentation posted November 9, 2026 with supplemental information for quarter ended September 30, 2026
  • Presentation available through Turning Point Brands’ investor relations events and presentations page
  • Supplemental materials may provide additional operating and financial context beyond the quarterly filing

Item EX-99.1 · Exhibit EX-99.1

  • Q3 2026 revenue $151.1M, up 27.0%, led by Modern Oral and Stoker’s growth
  • Modern Oral net sales $74.4M, up 102.9%, now 49.2% of company sales
  • Profitability weakened: net income $3.9M, down 81.4%, and Adjusted EBITDA $18.4M, down 41.3%
  • SG&A rose 69.1% to $75.3M, reflecting sales investments, FDA PMTA costs and higher outbound freight
  • FY 2026 guidance reaffirmed: Modern Oral net sales $260-$270M and Adjusted EBITDA $70-$80M

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Turning Point Brands, Inc. 8-K filings

Get the next TPB 8-K as it lands

Follow TPB for push alerts, or ask the research agent what this filing means.